Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.37 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.37 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.32 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.32 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.31 |
| ▸ | RELA | Q04206 | 1/20 | 0.31 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7719558 | 0.86 | HDAC6 (0.38) | HDAC6HDAC1HDAC2KDM4EMEN1 | |
| SCHEMBL7248146 | 0.85 | MEN1 (0.38) | HDAC6HDAC1HDAC2MEN1GAA | |
| SCHEMBL27606643 | 0.85 | MEN1 (0.31) | HDAC6HDAC1HDAC2MEN1GAA | |
| SCHEMBL27505816 | 0.82 | MGAM (0.38) | HDAC6HDAC1HDAC2KDM4EGAA | |
| SCHEMBL98566 | 0.82 | GLRA1 (0.47) | HDAC6HDAC1HDAC2GLRA1SLC6A9 | |
| SCHEMBL3984281 | 0.81 | HDAC6 (0.39) | HDAC6HDAC1HDAC2NFKB1NFKB2 | |
| Glycine SCHEMBL28774225 | 0.79 | GLRA1 (0.39) | HDAC6HDAC1HDAC2GLRA1SLC6A9 | |
| SCHEMBL8606993 | 0.79 | HDAC6 (0.38) | HDAC6HDAC1HDAC2NFKB1NFKB2 | |
| SCHEMBL28195146 | 0.79 | MEN1 (0.33) | HDAC6HDAC1HDAC2MEN1GAA | |
| SCHEMBL28195145 | 0.79 | MEN1 (0.33) | HDAC6HDAC1HDAC2MEN1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112010943-B | To Cu2+Sensitive organic small molecule gel compound and preparation method and application thereof | 温州大学 | 2022-02-15 | — | — | CN | claimed |
| CN-112010943-A | To Cu2+Sensitive organic small molecule gel compound and preparation method and application thereof | 温州大学 | 2020-12-01 | — | — | CN | claimed |
| US-5130307-A | Antibody inhibitors; treating organ graft rejection, fungal infections; antiinflammatory agents | AMERICAN HOME PRODUCTS CORPORATION (US) | 1992-07-14 | — | — | US | claimed |
| CN-119219611-B | Near infrared fluorescent probe for actively targeting fibroblast growth factor receptor, and preparation method and application thereof | 南京诺源医疗器械有限公司 | 2025-04-18 | — | — | CN | disclosed |
| CN-119219607-B | Near infrared fluorescent probe for actively targeting vascular epidermal growth factor receptor detection and preparation method and application thereof | 南京诺源医疗器械有限公司 | 2025-02-25 | — | — | CN | disclosed |
| CN-119219607-A | Near infrared fluorescent probe for actively targeting vascular epidermal growth factor receptor detection and preparation method and application thereof | 南京诺源医疗器械有限公司 | 2024-12-31 | — | — | CN | disclosed |
| CN-119219611-A | Near infrared fluorescent probe for actively targeting fibroblast growth factor receptor, and preparation method and application thereof | 南京诺源医疗器械有限公司 | 2024-12-31 | — | — | CN | disclosed |
| CN-119080854-A | Cytidine nucleoside compound based on glycine, preparation method and application thereof, and bactericidal and antiviral composition | 沈阳农业大学 | 2024-12-06 | — | — | CN | disclosed |
| CN-118894839-A | Novel FAP inhibitor and application thereof | 中国药科大学 | 2024-11-05 | — | — | CN | disclosed |
| CN-118496232-A | Compound targeting tyrosine protein kinase BTK and application thereof | 北京康特莱斯医药科技有限公司 | 2024-08-16 | — | — | CN | disclosed |
| CN-112714649-B | Cyclic dinucleotide derivatives and antibody drug conjugates thereof | 第一三共株式会社 | 2024-07-02 | — | — | CN | disclosed |
| US-6034055-A | Glycosyl-amides of 2-aminoacylamino-2-deoxy-sugars | BAYER AKTIENGESELLSCHAFT (DE) | 2000-03-07 | — | — | US | disclosed |
| US-5905071-A | IMMUNE SYSTEM STIMULATORS | BAYER AKTIENGESELLSCHAFT (DE) | 1999-05-18 | — | — | US | disclosed |
| CN-1215397-A | Acylated N-hydroxymethylthalidomide prodrugs with immunomodulator activity | GRUENENTHAL GMBH (DE) | 1999-04-28 | — | — | CN | disclosed |
| EP-0655065-B1 | 27-HYDROXYRAPAMYCIN AND DERIVATIVES THEREOF | AMERICAN HOME PROD (US) | 1996-12-11 | — | — | EP | disclosed |
| US-5302600-A | Inducing immunosuppression; antiinflammatory agents, antifungal, antitumor and antiproliferative agents | AMERICAN HOME PRODUCTS CORPORATION (US) | 1994-04-12 | — | — | US | disclosed |
| US-5256790-A | Antibiotic | AMERICAN HOME PRODUCTS CORPORATION (US) | 1993-10-26 | — | — | US | disclosed |
| US-5130307-A | Antibody inhibitors; treating organ graft rejection, fungal infections; antiinflammatory agents | AMERICAN HOME PRODUCTS CORPORATION (US) | 1992-07-14 | — | — | US | disclosed |
| US-4169141-A | 1-Peptidyl derivatives of di-O-aminoglycosyl-1,3-diaminocyclitol antibacterial agents | SHERING CORPORATION (US) | 1979-09-25 | — | — | US | disclosed |
| US-4093610-A | CYCLIC DODECAPEPTIDE, MULTISTAGE | AMERICAN HOME PRODUCTS CORPORATION (US) | 1978-06-06 | — | — | US | disclosed |